Immunodiagnostic Systems says 2015 was not a successful year
23rd Jun 2015 09:43
Immunodiagnostic Systems, a medical diagnostic products manufacturer, said its full-year was not a successful one, with a decline in revenues, the underperformance of its innovation process and sales failing to deliver. The group saw a significant fall in income related to its vitamin D measurement
Read moreImmundiagnostic Systems plunges on revenue warning
29th May 2015 09:18
Shares in Immunodiagnostic Systems Holdings plunged over 10% early on Friday, as the medical diagnostic products manufacturer said it was anticipating another year of falling revenues. In a trading update, the London-listed company said it expected revenues to fall to between £39m and £42m in the ye
Read moreImmunodiagnostic Systems chairman follows CEO and resigns
25th Nov 2014 09:29
The chairman of Immunodiagnostic Systems has decided to follow the company's chief executive (CEO) and step down after the AIM-listed firm's declining first-half revenues and profits highlighted the difficulties affecting its strategy. Half-year results, which had been previewed by the group in mid-
Read moreTuesday broker round-up UPDATE
14th Oct 2014 09:17
Anglo Pacific: FinnCap upgrades to buy with a target price of 158p. Peel Hunt shifts target price from 196p to 198p retaining its buy recommendation. Ashmore: Canaccord Genuity upgrades from sell to hold with a target price of 300p. Numis cuts target price from 369p to 355p retaining an add rating.
Read moreImmunodiagnostics warns revenues will miss expectations
15th Sep 2014 13:13
Immunodiagnostic Systems was a big faller on Monday after warning that revenues will be below current expectations after experiencing continued low levels of placements, an acceleration in the decline in manual revenues and currency headwinds. The group predicts its revenues for the year ending 31 M
Read moreThursday broker round-up UPDATE
21st Aug 2014 11:34
Beowulf Mining: Cantor Fitzgerald places its target price under review, while keeping a buy recommendation. Cairn Energy: Investec ups target price from 220p to 245p and reiterates a buy recommendation. Carillion: Oriel reinstates with a target price of 402p and a buy recommendation. Gem Diamonds
Read moreTuesday broker round-up UPDATE
12th Aug 2014 09:25
African Barrick Gold: Investec ups target price from 212p to 260p upgrading from sell to hold. Al Noor Hospotals: Jefferies cuts target price from 1155p to 1125p and maintains a buy recommendation. Aquarius Platinum: Citi shifts target price from 22p to 26p and keeps a neutral rating. BHP Billito
Read moreWednesday broker round-up UPDATE
23rd Jul 2014 09:01
Abcam: Canaccord Genuity ups target price from 375p to 400p and upgrades from hold to buy. ARM Holdings: Deutsche Bank cuts target price from 975p to 950p and maintains a hold recommendation. Credit Suisse lowers target price from 1125p to 1100p and leaves its outperform rating unaltered. Beazley:
Read moreImmunodiagnostic ups dividend and unveils bullish five-year plan
24th Jun 2014 11:02
Final results from Immunodiagnostic Systems (IDS) were broadly in line with expectations, as the company outlined a new five-year strategy to double revenues by increasing the installed base of its IDS-iSYS instruments and its menu of tests. The AIM-listed company confirmed, as per its update in A
Read moreThursday broker round-up UPDATE
19th Jun 2014 08:56
BAE Systems: Westhouse Securities initiates with a target price of 360p and a sell recommendation. Berkeley Group: Deutsche Bank increases target price from 2587p to 2877p retaining a hold recommendation. Jefferies raises target price from 2477p to 2543p and keeps a hold recommendation. BG Group:
Read moreSector movers: Healthcare stocks rise as M&A fever continues
24th Apr 2014 15:41
Global M&A activity gave stocks in the healthcare equipment and services a boost on Thursday, with Smith & Nephew rising strongly after a takeover bid for sector peer Biomet. US artificial joint maker Zimmer Holdings announced today that it would buy orthopaedic products group Biomet in a deal valu
Read moreImmunodiagnostics Systems in line but placements disappoint
15th Apr 2014 13:10
Immunodiagnostics Systems (IDS) said results will be in line with expectations for the full year, but admitted its placement of instruments with customers was disappointing. The AIM-listed company said total revenues would be roughly £52.3m, up 5% year-on-year driven primarily by the growth from it
Read moreSector movers: Mobile telecoms, healthcare stocks rise as results impress
6th Feb 2014 14:02
The mobile telecoms and healthcare categories were putting in decent performances on Thursday in London after results from sector heavyweights Vodafone and Smith & Nephew impressed. Vodafone gained 2.4% in afternoon trade after revenues declined by a less-than-expected 3.6% in the third quarter to
Read moreWednesday broker round-up UPDATE
27th Nov 2013 09:14
Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation. Bellway: Numis upgrades to buy with a target price of 1690p. Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation. Britvic: UBS ups target price from 575p to 600p and keeps a neu
Read moreMonday broker round-up UPDATE
25th Nov 2013 08:00
African Barrick Gold: Goldman Sachs ups target price from 110p to 140p, but still recommends selling. Alternative Asset Opps: Westhouse Securities initiates with a buy recommendation. Amino Technology: Northland Capital cuts target price from 110p to 100p and downgrades from buy to hold. Asian Pl
Read more